Skip to main content

Abnormality in Synovial Tissue

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
Examination of Biopsies From Healthy Knee JointsN/A1 trial
Active Trials
NCT02458170Terminated43Est. Dec 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Novo NordiskExamination of Biopsies From Healthy Knee Joints

Clinical Trials (1)

Total enrollment: 43 patients across 1 trials

NCT02458170Novo NordiskExamination of Biopsies From Healthy Knee Joints

Examination of Biopsies From Healthy Knee Joints

Start: Aug 2013Est. completion: Dec 201443 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.